Weycker Derek, Averin Ahuva, Houde Linnea, Ottino Kevin, Shea Kimberly, Sato Reiko, Gessner Bradford D, Yacisin Kari, Curcio Daniel, Begier Elizabeth, Rozenbaum Mark
Policy Analysis Inc. (PAI), Boston, MA, USA.
Pfizer Inc., New York, NY, USA.
Infect Dis Ther. 2024 Jan;13(1):207-220. doi: 10.1007/s40121-023-00904-z. Epub 2024 Jan 18.
While it is widely recognized that older adults, adults with chronic medical conditions (CMC), and adults with immunocompromising conditions (IC) are at increased risk of lower respiratory tract illness (LRTI), evidence of the magnitude of increased risk is limited. This study was thus undertaken to characterize rates of hospitalized and ambulatory LRTI among United States (US) adults by age and comorbidity profile.
A retrospective cohort design and US healthcare claims database (2016-2019) were employed. Study population included adults aged ≥ 18 years and was stratified by age and comorbidity profile (CMC-, CMC+ , IC). LRTI was ascertained overall and by pathogen pathogen (e.g., respiratory syncytial virus [RSV]), and was classified by care setting (hospital, emergency department [ED], physician office/hospital outpatient [PO/HO]).
Relative rates (RR) of LRTI generally increased with older age across care settings (vs. 18-49 years), with the most marked increase for hospitalizations: for LRTI-hospitalized, RRs ranged from 3.3 for 50-64 years to 46.6 for ≥ 85 years; for LRTI-ED and LRTI-PO/HO, RRs ranged from 1.0 to 2.7 and from 1.3 to 1.5, respectively. Within age groups, LRTI rates were also consistently higher among CMC+ and IC adults (vs. CMC- adults). Age-specific RRs of LRTI patients hospitalized due to RSV were largely comparable to overall LRTI; age-specific RRs for other care settings, and RRs for CMC+ and IC adults (vs. CMC- adults), were generally higher for LRTI due to RSV.
Incidence of LRTI, including that due to RSV, especially for events requiring acute inpatient care, is markedly higher among older adults and adults of all ages with CMC or IC.
虽然人们普遍认识到老年人、患有慢性疾病(CMC)的成年人以及免疫功能低下(IC)的成年人患下呼吸道疾病(LRTI)的风险增加,但风险增加幅度的证据有限。因此,本研究旨在按年龄和合并症情况描述美国成年人住院和非住院LRTI的发生率。
采用回顾性队列设计和美国医疗保健索赔数据库(2016 - 2019年)。研究人群包括年龄≥18岁的成年人,并按年龄和合并症情况(无慢性疾病、有慢性疾病、免疫功能低下)进行分层。总体上确定LRTI并按病原体(如呼吸道合胞病毒[RSV])确定,同时按护理环境(医院、急诊科[ED]、医生办公室/医院门诊[PO/HO])进行分类。
在所有护理环境中,LRTI的相对发生率(RR)通常随年龄增长而增加(与18 - 49岁相比),住院情况的增加最为明显:对于住院LRTI,RR范围从50 - 64岁的3.3到85岁及以上的46.6;对于急诊LRTI和门诊LRTI,RR分别为1.0至2.7和1.3至1.5。在各年龄组中,患有慢性疾病和免疫功能低下的成年人的LRTI发生率也始终高于无慢性疾病的成年人。因RSV住院的LRTI患者的年龄特异性RR与总体LRTI基本相当;其他护理环境的年龄特异性RR以及患有慢性疾病和免疫功能低下的成年人(与无慢性疾病的成年人相比)的RR,因RSV导致的LRTI通常更高。
LRTI的发生率,包括由RSV引起的LRTI,特别是对于需要急性住院治疗的情况,在老年人以及所有年龄段患有慢性疾病或免疫功能低下的成年人中明显更高。